Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kathleen Lasance"'
Autor:
Wei Huang, Bo Dai, Zhili Wen, Ronald W Millard, Xi-Yong Yu, Kristin Luther, Meifeng Xu, Ting C Zhao, Huang-Tian Yang, Zhihua Qi, Kathleen Lasance, Muhammad Ashraf, Yigang Wang
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70023 (2013)
OBJECTIVE:The purpose of this study was to assess the effect of collagen composition on engraftment of progenitor cells within infarcted myocardium. BACKGROUND:We previously reported that intramyocardial penetration of stem/progenitor cells in epicar
Externí odkaz:
https://doaj.org/article/a51dc0b082b14502802745f7084e9ec4
Autor:
Pankaj B. Desai, Xiaoyang Qi, Kathleen LaSance, Gary A. Gudelsky, Lionel M.L. Chow, Nimita Dave
We present data that letrozole, an extensively used aromatase inhibitor in the treatment of estrogen receptor–positive breast tumors in postmenopausal women, may be potentially used in the treatment of glioblastomas. First, we measured the in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bbcc865aafa47ab4f1a6e6712a78356
https://doi.org/10.1158/1535-7163.c.6536619.v1
https://doi.org/10.1158/1535-7163.c.6536619.v1
Autor:
Pankaj B. Desai, Xiaoyang Qi, Kathleen LaSance, Gary A. Gudelsky, Lionel M.L. Chow, Nimita Dave
Supplementary Figure 1. Correlation between observed cytotoxicity (MTT assay) and Inhibition of Aromatase Activity (EIA assay). Supplementary Table 1. Active tumor volumes obtained from μPET/CT scans of individual rats from control and treatment gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70dba1dd68395a132bc4657cf57b0b81
https://doi.org/10.1158/1535-7163.22500900.v1
https://doi.org/10.1158/1535-7163.22500900.v1
Autor:
Hala E. Thomas, Jack Rubinstein, Lowell B. Anthony, Carol A. Mercer, Xiaoyang Qi, Kakajan Komurov, David R. Plas, Hanan M. Dahche, Vinicius S. Carreira, Sheryl E. Koch, Kathleen LaSance, Mariah Worley, Min Jiang, Zhengtao Chu, Melissa A. Orr-Asman
Inhibition of mTOR signaling using the rapalog everolimus is an FDA-approved targeted therapy for patients with lung and gastroenteropancreatic neuroendocrine tumors (NET). However, patients eventually progress on treatment, highlighting the need for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64aae7793335e011bc4ba3984f311be0
https://doi.org/10.1158/1535-7163.c.6538789
https://doi.org/10.1158/1535-7163.c.6538789
Autor:
Hala E. Thomas, Jack Rubinstein, Lowell B. Anthony, Carol A. Mercer, Xiaoyang Qi, Kakajan Komurov, David R. Plas, Hanan M. Dahche, Vinicius S. Carreira, Sheryl E. Koch, Kathleen LaSance, Mariah Worley, Min Jiang, Zhengtao Chu, Melissa A. Orr-Asman
Table S1. CC-223-treated mice tend to develop less histopathologic lesions of the heart valves than either rapamycin- or placebo-treated mice. Figure S1. MLN0128 inhibited mTOR signaling in human pNET cell lines in a dose-dependent manner. Figure S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d90b178ee84c8bf4d1cc19a4cbef7c1
https://doi.org/10.1158/1535-7163.22507783
https://doi.org/10.1158/1535-7163.22507783
Autor:
Zhihua Qi, Adeola Adeyemo, Andrew Stiene, Jo El J. Schultz, Christopher Johnson, Lisa Lemen, Kathleen LaSance
Publikováno v:
Growth Factors
FGF2 is a potent stimulator of vascular growth; however, even with a deficiency of FGF2 (Fgf2-/-), developmental vessel growth or ischaemia-induced revascularization still transpires. It remains to be elucidated as to what function, if any, FGF2 has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8904129d919d1c376a803b61e568212c
Autor:
Vinicius Carreira, Kakajan Komurov, Lowell Anthony, Min Jiang, Sheryl E. Koch, Zhengtao Chu, Xiaoyang Qi, David R. Plas, Hanan M. Dahche, Carol A. Mercer, Jack Rubinstein, Kathleen LaSance, Hala Elnakat Thomas, Mariah Worley, Melissa A. Orr-Asman
Publikováno v:
Molecular Cancer Therapeutics. 16:2432-2441
Inhibition of mTOR signaling using the rapalog everolimus is an FDA-approved targeted therapy for patients with lung and gastroenteropancreatic neuroendocrine tumors (NET). However, patients eventually progress on treatment, highlighting the need for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5bba57404889de6288d35a74317af64
https://doi.org/10.1158/1535-7163.mct-17-0058
https://doi.org/10.1158/1535-7163.mct-17-0058
Autor:
Koon Y. Pak, Kenneth D. Greis, Xiaoyang Qi, Brian D. Gray, Zhengtao Chu, Víctor M. Blanco, Kathleen LaSance, Therese Rider
Publikováno v:
Oncotarget
// Victor M. Blanco 1 , Zhengtao Chu 1, 2 , Kathleen LaSance 3 , Brian D. Gray 4 , Koon Yan Pak 4 , Therese Rider 5 , Kenneth D. Greis 5 , Xiaoyang Qi 1, 2 1 Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d988626f908eba2dcaac1e195a2f08a3
https://doi.org/10.18632/oncotarget.8763
https://doi.org/10.18632/oncotarget.8763
Autor:
Farzin Haque, Chia-Yang Liu, Liang Feng, Peixuan Guo, Kathleen LaSance, Dan Shu, Hongshan Liu, S. Kevin Li
Publikováno v:
Pharmaceutical Research. 31:1046-1058
RNA nanoparticles derived from the three-way junction (3WJ) of the pRNA of bacteriophage phi29 DNA packaging motor were previously found to be thermodynamically stable. As the nanoparticles could have potential in ocular drug delivery, the objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204fd016664aec721dcfa09ec205ec22
https://doi.org/10.1007/s11095-013-1226-x
https://doi.org/10.1007/s11095-013-1226-x
Autor:
Lisa C. Lemen, Bhushan Vilas Kulkarni, Stephen C. Woods, Kathleen LaSance, Darleen A. Sandoval, Joyce Sorrell, Randy J. Seeley
The mechanisms involved in the weight loss seen after vertical sleeve gastrectomy (VSG) are not clear. The rat stomach has two morphologically and functionally distinct proximal and distal parts. The rat model for VSG involves complete removal of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ba9edfd248be16ebbf3ed58f250d0e
https://europepmc.org/articles/PMC5130580/
https://europepmc.org/articles/PMC5130580/